source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

EVENT PREVIEW: Get ready for DCAT Week in New York this month!

DCAT Week, organised and hosted by the US-based Drug, Chemical & Associated Technologies Association (DCAT), is one of the major international business development events for companies working in the pharmaceutical and related industries. It takes place in March every year as…

Sphere Fluidics closes $2 million investment round

Sphere Fluidics, a company commercialising single-cell analysis systems using picodroplet-based technology, has closed a $2 million investment round with funding from several investors including Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket. The funds will be used…

Optibrium appoints Clare Devlin as financial director

Drug discovery software development specialist Optibrium has appointed Clare Devlin as its financial director. As well as managing all financial aspects of the business, Devlin will be part of the senior team developing business strategy and objectives. She has extensive…

Evonetix appoints Stephanie Brooking as Head of Product Management

Cambridge, UK-based EVONETIX LTD, a company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has appointed Stephanie Brooking as Head of Product Management. Evonetix aims to utilise its innovative silicon chip approach to deliver a high-throughput solution for…

Evonetix establishes scientific advisory board

EVONETIX LTD, a Cambridge, UK-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has formed a scientific advisory board (SAB) with the appointment of Professor David Klenerman FMedSci FRS and Professor Andrew Briggs to advise the company…
Subscribe to this RSS feed